Your browser doesn't support javascript.
loading
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).
Baden, Lindsey R; Walsh, Stephen R; Seaman, Michael S; Johnson, Jennifer A; Tucker, Robert P; Kleinjan, Jane A; Gothing, Jon A; Engelson, Brian A; Carey, Brittany R; Oza, Avinash; Bajimaya, Shringkhala; Peter, Lauren; Bleckwehl, Chelsea; Abbink, Peter; Pau, Maria G; Weijtens, Mo; Kunchai, Meghan; Swann, Edith M; Wolff, Mark; Dolin, Raphael; Barouch, Dan H.
Affiliation
  • Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts.
  • Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts.
  • Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts.
  • Johnson JA; Division of Infectious Diseases, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts.
  • Tucker RP; Division of Infectious Diseases, Brigham and Women's Hospital.
  • Kleinjan JA; Division of Infectious Diseases, Brigham and Women's Hospital.
  • Gothing JA; Division of Infectious Diseases, Brigham and Women's Hospital.
  • Engelson BA; Division of Infectious Diseases, Brigham and Women's Hospital.
  • Carey BR; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Oza A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Bajimaya S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Bleckwehl C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center.
  • Pau MG; Crucell Holland BV, Leiden, the Netherlands.
  • Weijtens M; Crucell Holland BV, Leiden, the Netherlands.
  • Kunchai M; EMMES Corporation, Rockville.
  • Swann EM; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
  • Wolff M; EMMES Corporation, Rockville.
  • Dolin R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts.
J Infect Dis ; 210(7): 1052-61, 2014 Oct 01.
Article in En | MEDLINE | ID: mdl-24719474
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gene Expression / Adenoviruses, Human / HIV-1 / AIDS Vaccines / Capsid Proteins / Env Gene Products, Human Immunodeficiency Virus Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2014 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gene Expression / Adenoviruses, Human / HIV-1 / AIDS Vaccines / Capsid Proteins / Env Gene Products, Human Immunodeficiency Virus Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2014 Type: Article